References
- European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182–236.
- American Association for the Study of Liver Diseases. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67(1):358–380.
- Kondo Y, Yoshida H, Tateishi R, et al. Percutaneous radiofrequency ablation of liver cancer in the hepatic dome using the intrapleural fluid infusion technique. Br J Surg. 2008;95(8):996–1004.
- Minami Y, Kudo M, Kawasaki T, et al. Percutaneous ultrasound-guided radiofrequency ablation with artificial pleural effusion for hepatocellular carcinoma in the hepatic dome. J Gastroenterol. 2003;38(11):1066–1070.
- Dezhi Z, Ping L, Xiaoling Y, et al. The value of artificial pleural effusion for percutaneous microwave ablation of liver tumour in the hepatic dome: a retrospective case-control study. Int J Hyperth. 2013;29(7):663–670.
- De BT, Dromain CM, Briggs P, et al. Artificially induced pneumothorax for percutaneous transthoracic radiofrequency ablation of tumors in the hepatic dome: initial experience. Radiology. 2005;236(2):666–670.
- Hyunchul R, Lim Hyo K, Young-Sun K, et al. Percutaneous radiofrequency ablation with artificial ascites for hepatocellular carcinoma in the hepatic dome: initial experience. AJR: Am J Roentgenol. 2008;32(5):109–109.
- Hermida M, Cassinotto C, Piron L, et al. Percutaneous thermal ablation of hepatocellular carcinomas located in the hepatic dome using artificial carbon dioxide pneumothorax: retrospective evaluation of safety and efficacy. Int J Hyperth. 2018;35(1):90–96.
- Fujiwara H, Arai Y, Ishii H, et al. Computed tomography-guided radiofrequency ablation for sub-diaphragm hepatocellular carcinoma: safety and efficacy of inducing an artificial pneumothorax. Acta Med Okayama. 2016;70(3):189–195.
- Shibata T, Shibata T, Maetani Y, et al. Transthoracic percutaneous radiofrequency ablation for liver tumors in the hepatic dome. J Vasc Interv Radiol. 2004;15(11):1323–1327.
- Kim YK, Kim CS, Lee JM, et al. Efficacy and safety of radiofrequency ablation of hepatocellular carcinoma in the hepatic dome with the CT-guided extrathoracic transhepatic approach. Eur J Radiol. 2006;60(1):100–107.
- Park SW, Kim Y, Kang HY, et al. Transthoracic radiofrequency ablation for hepatic tumor located beneath the diaphragm under one-lung ventilation: a case report. Medicine (Baltimore). 2018;97(51):e13863.
- Brennan DD, Ganguli S, Brecher CW, et al. Thinking outside the abdominal box: safe use of the epipericardial fat pad window for percutaneous radiofrequency ablation of hepatic dome tumors. J Vasc Interv Radiol. 2008;19(1):133–136.
- D’Amico F, Serafini S, Finotti M, et al. One-lung ventilation to treat hepatic dome lesion – a further step towards minimally invasive surgery: a case report. J Med Case Rep. 2019;13(1):83–86.
- Bernasconi F, Piccioni F. One-lung ventilation for thoracic surgery: current perspectives. Tumori. 2017;103(6):495–503.
- Mcgrath B, Tennuci C, Lee G. The history of one-lung anesthesia and the double-lumen tube. J Anesth Hist. 2017;3(3):76–86.
- Wang G, Sun Y, Cong L, et al. Artificial pleural effusion in percutaneous microwave ablation of hepatic tumors near the diaphragm under the guidance of ultrasound. Int J Clin Exp Med. 2015;8(9):16765–16771.
- Koda M, Ueki M, Maeda Y, et al. Percutaneous sonographically guided radiofrequency ablation with artificial pleural effusion for hepatocellular carcinoma located under the diaphragm. AJR: Am J Roentgenol. 2004;183(3):583–588.
- Ishikawa T, Imai M, Ko M, et al. Effect of treatment support on preventing local recurrence of hepatocellular carcinoma directly adjacent to the diaphragm. Mol Clin Oncol. 2017;7(1):61–66.
- Hsieh YC, Limquiaco JL, Lin CC, et al. Radiofrequency ablation following artificial ascites and pleural effusion creation may improve outcomes for hepatocellular carcinoma in high-risk locations. Abdom Radiol. 2019;44(3):1141–1151.